What type of test is MyRisk?

• A. A germline hereditary cancer test
• B. A somatic tumor test
• C. A pharmacogenomic test
• D. A microbiome test

Answer: (A)

MyRisk is a germline hereditary cancer risk assessment test. It analyzes inherited DNA from normal cells (such as blood or saliva) to identify pathogenic variants in cancer predisposition genes. This information helps estimate an individual’s lifetime cancer risk and guide appropriate screening, risk-reduction strategies, and cascade testing for family members. It is not analyzing tumor DNA, which would be a somatic tumor test used to guide treatment; it is not pharmacogenomic testing, which looks at how genes affect drug metabolism and response; and it is not a microbiome test, which examines gut microbial composition.